AMKR vs FORM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AMKR demonstrates strong financial health with a Piotroski F-Score of 8/9, indicating robust operational efficiency and profitability trends. The company trades at a forward P/E of 18.15, below the sector average of 77.27, suggesting relative undervaluation despite high growth expectations. Earnings growth of 61% YoY and consistent earnings beats (3/4 in last 4 quarters) reinforce its momentum. However, the absence of an Altman Z-Score and bearish insider activity (4 sales totaling $2.83M) introduce cautionary signals. The intrinsic value of $44.25 exceeds the current price of $41.61, supporting a fair value upside.
FormFactor exhibits exceptional operational health with a Piotroski F-Score of 8/9 and a negligible debt-to-equity ratio of 0.03. However, the stock is currently experiencing a severe valuation disconnect, trading at $121.07—nearly 6x its growth-based intrinsic value ($20.06) and significantly above the analyst target price of $86.89. While earnings growth is explosive (131.8% YoY), the P/E ratio of 178.04 is unsustainable. The combination of aggressive insider selling and a bearish technical trend suggests the current price is driven by momentum rather than fundamental value.
Compare Another Pair
Related Comparisons
AMKR vs FORM: Head-to-Head Comparison
This page compares Amkor Technology, Inc. (AMKR) and FormFactor, Inc. (FORM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.